Sagent Pharmaceuticals Reports Data Incident to New Hampshire AG

On May 1, 2026, Sagent Pharmaceuticals officially reported a data security incident to the New Hampshire Attorney General's office. This public filing confirms that the company, which develops and distributes injectable pharmaceutical products, experienced a security event that could impact individuals.

The report indicates that unauthorized parties may have gained access to internal systems maintained by Sagent Pharmaceuticals. While the specific categories of information involved are not detailed in the public record, the company's notification suggests that personal information of certain individuals may have been compromised during this incident.

If you have received a formal data breach notification letter directly from Sagent Pharmaceuticals, it means your personal information was likely contained within the files accessed by the unauthorized party. These letters are sent to inform you about the incident and its potential impact on your data.

To help protect yourself, it is generally recommended to review any specific advice provided in your official notification from Sagent Pharmaceuticals. Common protective measures include monitoring your financial accounts and credit reports for any unusual or suspicious activity. Remaining vigilant for unexpected communications or requests for personal details is also a prudent step.

The investigation into the scope and nature of this incident is ongoing, as noted in the official filing. Sagent Pharmaceuticals will provide further details directly to affected individuals as the investigation progresses and more information becomes available. Always refer to official company communications for the most accurate and current information regarding your specific situation.